DNLI R&D to Revenue

Denali Therapeutics Inc · R&D to Revenue

DNLI logo

DNLI R&D to Revenue

Latest reported0.00%
DNLI FY R&D/Revenue (0.00% → 0.00%)
High-resolution chart · PNG

DNLI r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Denali Therapeutics Inc R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
0%
0%
128.2409%
330.7414%
545.3094%
63.3426%
724.8744%
110.8571%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.